Member Info for shareguard

My understanding from pmg they sold the 29K units just waiting for install quote you dont buy them just to keep them in the garage. So paid for just not receiving the monitoring side money but that will come.

Well my understanding of it until they draw on the convertible loan there is nothing to gain by that, The original money is for keeps whatever happens full stop.

First thanks to all who attended the presentation and for the video i have watched it twice now and cant help feeling Paul intentionally or not uses the term way more in his speech once around 29mins and twice at around 35mins. I know being Aussie he can be excused the English but cant help feeling he has been talking to Waymo a lot or its a cryptic signal from him particular the Two around 35 mins.
What a great presentation and i am feeling waymo positive going into the weekend thanks again everybody.

Silence is killing me half expecting to hear all attendees had to sign NDA's or had thier phones confiscated.

Mobileye
"Mobileye notes ~800 vehicles incorporate its EyeQ system, with over 8.6 billion miles of road data collected"
That statement by Mobileye is a tad misleading how have they collected 8.6 billion miles of data in just 800 cars they must have been to the moon and back several times.

Ahh coldfishpie your unfounded dismissal of seeingmachines unrivalled DMS solution led you to buy a car with inferior product .
https://www.youtube.com/watch?v=pOiB-jmU2PE
Them builders should never have left them planks leading into the skip .

Well i think we can all agree that scancell keep a watertight lid on news a 14.00 rns a lot of the herd will have missed it expect a few new investors to appear tomorrow .

https://www.bbc.co.uk/news/uk-england-london-62044136
This poor girl was badly let down by her initial diagnosis cant believe what her initial dermatologist said just shows how getting the right doctor can be a bit of a lottery. When i had it mine said it doesnt look like cancer but we will cut it off .
Feeling lucky this morning, come on Scancell .

cfp If its the same Ouija board you use on your AFC company you can stick it were the sun doesnt shine we are doing just fine without it.

Hi cleaner no mention of Scancell in the podcast but the write up about it underneath refers to Scancell twice.

Will probably get to know more tomorrow investor presentation in the afternoon hope the 7% increase on Friday was a clue to the way it will go.

The Group will also conduct an investor presentation which will follow the publication of the Group's final results. The event will take place at 2.00pm on Monday 18 July with Bill Brown (Chairman) and Caroline Stretton (Group Managing Director) presenting from the Company.The online presentation is open to all existing and potential shareholders. Questions can be submitted during the presentation to be addressed at the end.

To register for the event, please visit www.equitydevelopment.co.uk/news-and-events/rua-life-sciences-fyresults-18july2022.A recording of the presentation will be available shortly afterwards on the Equity Developments website.

Hi Burble you are a great asset to this board and thanks for your input how a company that gets peer reviewed articles in a leading American journal like the one below can be classed as self promoting think the reviewer keeping us under the radar while he gets invested.
Publication highlights potential of AvidiMab
Fri, 12th Jun 2020 09:30

RNS Number : 8070P
Scancell Holdings Plc
12 June 2020

12 June 2020



Scancell Holdings plc

("Scancell" or the "Company")



Peer reviewed publication highlights potential of AvidiMab™ to enhance the potency of any therapeutic antibody





Scancell Holdings plc, (AIM:SCLP), the developer of novel immunotherapies for the treatment of cancer, is pleased to note the publication of its manuscript in Cancer Research, a journal of the American Association of Cancer Research (AACR), entitled: "Engineering the human Fc-region enables direct cell killing by cancer glycan-targeting antibodies without the need for immune effector cells or complement".1



The paper describes how Scancell's AvidiMab™ modifications to the constant region (Fc) of any antibody can improve avidity, or strength of interaction, between the antibody and its target antigen, thereby improving the antibody's potential therapeutic properties. This same modification also has demonstrated that Scancell's own tumour-associated glycan (TaG) antibodies can directly kill tumour cells.



In recent years, antibodies have become the best-selling drugs in the pharmaceutical market and have been approved for treating various human diseases, including many cancers, autoimmune, metabolic and infectious diseases. The global therapeutic monoclonal antibody market is estimated to be US$150 billion in 2019 and predicted to grow to US$300 billion by 2025.2



The ability to increase the potential therapeutic properties of any antibody would therefore be seen as highly advantageous. Scancell has used its AvidiMab™ technology to increase the avidity of its TaG antibodies, and these are currently being evaluated for the treatment of cancer. They are also being developed as antibody-drug conjugates (ADC).3



Professor Lindy Durrant, Chief Scientific Officer of Scancell and Corresponding Author, commented:



"We are pleased to have our work published in the prestigious, peer reviewed journal, Cancer Research. Our AvidiMab™ technology increases the avidity of human antibodies by promoting non-covalent Fc-Fc interactions. This modification also causes direct killing of cancer cells by our glycan targeting antibodies, and therefore we believe this technology has the ability to create superior candidates for cancer immunotherapy."

Violin
Continuing the marathon analogy...I hope we are on the last few laps.
I think we may have just entered the Olympic stadium ready to claim the Gold medal.

just to confirm the 10000 before was a little top up for me at the same price

I am hoping its nvidia cars and then into the family of vr headsets bring it on occula .

Crackin bit of news Chelsea the ISA Pharma tie up for AMPLIVANT looks good to me for starters.

Great find Bermuda but whats interesting is the fact the writer is a patent attorney he has a lot of knowledge about the vaccines maybe he has worked on the patents for scancell see his footnote at the end of the article,

Its not going anywhere while this war going on who cant see the markets are spooked money goes into defensive stocks and gold etc .

Bill Gates doesnt think its over and i dont think many others do, but life goes on and we have to learn or maybe accept that we are stuck with covid like flu. Unless someone comes up with a game changer vaccine could be us or whoever but we need it.
https://www.ft.com/content/c1ab6cee-4f84-4a85-9c53-9f5f444359d4

https://www.bbc.co.uk/news/world-europe-59647069

Paris largest taxi firm suspends cars after fatal crash.